139 related articles for article (PubMed ID: 28957940)
1. Comparison of acute and convalescent biomarkers of inflammation in patients with acute pulmonary embolism treated with systemic fibrinolysis vs. placebo.
Stewart LK; Nordenholz KE; Courtney M; Kabrhel C; Jones AE; Rondina MT; Diercks DB; Klinger JR; Kline JA
Blood Coagul Fibrinolysis; 2017 Dec; 28(8):675-680. PubMed ID: 28957940
[TBL] [Abstract][Full Text] [Related]
2. Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial.
Kline JA; Nordenholz KE; Courtney DM; Kabrhel C; Jones AE; Rondina MT; Diercks DB; Klinger JR; Hernandez J
J Thromb Haemost; 2014 Apr; 12(4):459-68. PubMed ID: 24484241
[TBL] [Abstract][Full Text] [Related]
3. Absence of paradoxical thrombin activation by fibrin-specific thrombolytics in acute myocardial infarction: comparison of single-bolus tenecteplase and front-loaded alteplase.
Szabo S; Letsch R; Ehlers R; Walter T; Kazmaier S; Helber U; Hoffmeister HM
Thromb Res; 2002 Apr; 106(2):113-9. PubMed ID: 12182909
[TBL] [Abstract][Full Text] [Related]
4. Contribution of fibrinolysis to the physical component summary of the SF-36 after acute submassive pulmonary embolism.
Stewart LK; Peitz GW; Nordenholz KE; Courtney DM; Kabrhel C; Jones AE; Rondina MT; Diercks DB; Klinger JR; Kline JA
J Thromb Thrombolysis; 2015 Aug; 40(2):161-6. PubMed ID: 25433511
[TBL] [Abstract][Full Text] [Related]
5. Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary Embolism.
Stubblefield WB; Alves NJ; Rondina MT; Kline JA
PLoS One; 2016; 11(2):e0148747. PubMed ID: 26866684
[TBL] [Abstract][Full Text] [Related]
6. Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism.
Becattini C; Agnelli G; Salvi A; Grifoni S; Pancaldi LG; Enea I; Balsemin F; Campanini M; Ghirarduzzi A; Casazza F;
Thromb Res; 2010 Mar; 125(3):e82-6. PubMed ID: 19833379
[TBL] [Abstract][Full Text] [Related]
7. Rationale and methodology for a multicentre randomised trial of fibrinolysis for pulmonary embolism that includes quality of life outcomes.
Kline JA; Hernandez J; Hogg MM; Jones AE; Courtney DM; Kabrhel C; Nordenholz KE; Diercks DB; Rondina MT; Klinger JR
Emerg Med Australas; 2013 Dec; 25(6):515-26. PubMed ID: 24224521
[TBL] [Abstract][Full Text] [Related]
8. Tenecteplase to treat pulmonary embolism in the emergency department.
Kline JA; Hernandez-Nino J; Jones AE
J Thromb Thrombolysis; 2007 Apr; 23(2):101-5. PubMed ID: 17221330
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolysis for patients with intermediate-risk pulmonary embolism.
Meyer G; Vicaut E; Danays T; Agnelli G; Becattini C; Beyer-Westendorf J; Bluhmki E; Bouvaist H; Brenner B; Couturaud F; Dellas C; Empen K; Franca A; Galiè N; Geibel A; Goldhaber SZ; Jimenez D; Kozak M; Kupatt C; Kucher N; Lang IM; Lankeit M; Meneveau N; Pacouret G; Palazzini M; Petris A; Pruszczyk P; Rugolotto M; Salvi A; Schellong S; Sebbane M; Sobkowicz B; Stefanovic BS; Thiele H; Torbicki A; Verschuren F; Konstantinides SV;
N Engl J Med; 2014 Apr; 370(15):1402-11. PubMed ID: 24716681
[TBL] [Abstract][Full Text] [Related]
10. [Changes in oxidative stress and hemostatic parameters in the course of thrombolytic therapy of pulmonary embolism].
Mühl D
Orv Hetil; 2008 May; 149(20):935-48. PubMed ID: 18467263
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolysis for Acute Care of Pulmonary Embolism in the Intermediate Risk Patient.
Meyer G; Planquette B; Sanchez O
Curr Atheroscler Rep; 2015 Dec; 17(12):68. PubMed ID: 26486512
[TBL] [Abstract][Full Text] [Related]
12. Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial.
Giugliano RP; Roe MT; Harrington RA; Gibson CM; Zeymer U; Van de Werf F; Baran KW; Hobbach HP; Woodlief LH; Hannan KL; Greenberg S; Miller J; Kitt MM; Strony J; McCabe CH; Braunwald E; Califf RM;
J Am Coll Cardiol; 2003 Apr; 41(8):1251-60. PubMed ID: 12706917
[TBL] [Abstract][Full Text] [Related]
13. Endogenous plasma activated protein C levels and the effect of enoxaparin and drotrecogin alfa (activated) on markers of coagulation activation and fibrinolysis in pulmonary embolism.
Dempfle CE; Elmas E; Link A; Suvajac N; Liebe V; Janes J; Borggrefe M
Crit Care; 2011; 15(1):R23. PubMed ID: 21241489
[TBL] [Abstract][Full Text] [Related]
14. [Thrombus in transit and submassive pulmonary thromboembolism succesfully treated with tenecteplase].
Arboine-Aguirre L; Figueroa-Calderón E; Ramírez-Rivera A; Gaxiola-Cadena B; García-Sosa A; González-Garay C
Gac Med Mex; 2017; 153(1):129-133. PubMed ID: 28128817
[TBL] [Abstract][Full Text] [Related]
15. Massive pulmonary embolism immediately diagnosed by transthoracic echocardiography and treated with tenecteplase fibrinolysis.
Brunetti ND; Ieva R; Correale M; De Gennaro L; Pellegrino PL; Dioguardi E; Bux F; Di Biase M
J Thromb Thrombolysis; 2009 Aug; 28(2):238-41. PubMed ID: 18726674
[TBL] [Abstract][Full Text] [Related]
16. Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial.
Steering Committee
Am Heart J; 2012 Jan; 163(1):33-38.e1. PubMed ID: 22172434
[TBL] [Abstract][Full Text] [Related]
17. Thrombolysis With Single Bolus Tenecteplase Compared With Streptokinase Infusion in the Treatment of Acute Pulmonary Embolism: A Pilot Study.
Patra S; Nagesh CM; Reddy B; Srinivas BC; Agrawal N; Manjunath CN; Hegde M
Clin Appl Thromb Hemost; 2015 Sep; 21(6):550-7. PubMed ID: 24254898
[TBL] [Abstract][Full Text] [Related]
18. Microparticle-linked tissue factor activity and increased thrombin activity play a potential role in fibrinolysis failure in ST-segment elevation myocardial infarction.
Huisse MG; Ajzenberg N; Feldman L; Guillin MC; Steg PG
Thromb Haemost; 2009 Apr; 101(4):734-40. PubMed ID: 19350119
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group.
Agnelli G; Iorio A; Parise P; Goldhaber SZ; Levine MN
Blood Coagul Fibrinolysis; 1997 Jun; 8(4):216-22. PubMed ID: 9199818
[TBL] [Abstract][Full Text] [Related]
20. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
